ID

29939

Descripción

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.; ODM derived from: https://clinicaltrials.gov/show/NCT00698646

Link

https://clinicaltrials.gov/show/NCT00698646

Palabras clave

Versiones (1)
  1. 28/4/18 28/4/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

28 de abril de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hypertension NCT00698646

Inglés

Eligibility Hypertension NCT00698646

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 70 years or older.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
patients with hypertension prior to being randomized into study.
Descripción

Hypertensive disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020538
patients must have an office cuff mssbp ≥ 140 and ≤ 200 mmhg systolic.
Descripción

Sitting systolic blood pressure mean

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1319893
UMLS CUI [1,2]
C0444504
have the ability to communicate and comply with all study requirements.
Descripción

Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
provide written informed consent to participate in the study prior to any screening or study procedures.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of other investigational drugs within 30 days of enrollment.
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
history of hypersensitivity to any of the study drugs or to drugs of similar chemical classes.
Descripción

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Similar

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C2348205
office blood pressure measured by office machine cuff with a mean of (3) msdbp ≥ 120 mmhg at anytime during the screening / washout period.
Descripción

Blood pressure determination | Sitting diastolic blood pressure mean

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005824
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
patients taking 3 or more antihypertensive drugs and mssbp ≥ 160 mmhg at the time of visit 1.
Descripción

Antihypertensive Agents Quantity | Sitting systolic blood pressure mean

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
other protocol-defined exclusion criteria may apply
Descripción

Exclusion Criteria Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C2348563
Volver a la parte superior de la página

Similar models

Eligibility Hypertension NCT00698646

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 70 years or older.
boolean
C0001779 (UMLS CUI [1])
Hypertensive disease
Item
patients with hypertension prior to being randomized into study.
boolean
C0020538 (UMLS CUI [1])
Sitting systolic blood pressure mean
Item
patients must have an office cuff mssbp ≥ 140 and ≤ 200 mmhg systolic.
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
Protocol Compliance
Item
have the ability to communicate and comply with all study requirements.
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
provide written informed consent to participate in the study prior to any screening or study procedures.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs
Item
use of other investigational drugs within 30 days of enrollment.
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Similar
Item
history of hypersensitivity to any of the study drugs or to drugs of similar chemical classes.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
Blood pressure determination | Sitting diastolic blood pressure mean
Item
office blood pressure measured by office machine cuff with a mean of (3) msdbp ≥ 120 mmhg at anytime during the screening / washout period.
boolean
C0005824 (UMLS CUI [1])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Antihypertensive Agents Quantity | Sitting systolic blood pressure mean
Item
patients taking 3 or more antihypertensive drugs and mssbp ≥ 160 mmhg at the time of visit 1.
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Exclusion Criteria Study Protocol
Item
other protocol-defined exclusion criteria may apply
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial